- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/62 - Benzo [b] thiophenesHydrogenated benzo [b] thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
Patent holdings for IPC class C07D 333/62
Total number of patents in this class: 104
10-year publication summary
|
3
|
6
|
7
|
6
|
9
|
9
|
6
|
3
|
2
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Johns Hopkins University | 5821 |
6 |
| Cardioxyl Pharmaceuticals, Inc. | 46 |
6 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 176 |
6 |
| UCB Pharma GmbH | 83 |
6 |
| The University of Queensland | 663 |
6 |
| Kancera AB | 29 |
4 |
| Zomagen Biosciences Ltd | 18 |
3 |
| Merck Sharp & Dohme LLC | 3723 |
3 |
| Merck Patent GmbH | 5663 |
2 |
| Syngenta Participations AG | 1587 |
2 |
| Allergan, Inc. | 2208 |
2 |
| BioMarin Pharmaceutical Inc. | 384 |
2 |
| National University Corporation Hokkaido University | 1349 |
2 |
| Ono Pharmaceutical Co., Ltd. | 419 |
2 |
| Janssen Biopharma, Inc. | 32 |
2 |
| Ryvu Therapeutics SA | 47 |
2 |
| Lario Therapeutics Ltd | 13 |
2 |
| Hangzhou Phecdamed Co., Ltd. | 18 |
2 |
| Novartis AG | 10345 |
1 |
| F. Hoffmann-La Roche AG | 7839 |
1 |
| Other owners | 42 |